This ticker has not been starred yet CMRX Chimerix Inc
Pharmaceutical Preparations
Book value per $ invested $ 0.35
Leverage 14.43%
Market Cap $ 390.7m
PE 0.00
Dividend Yield 0.00%
Profit $ -83.0m
Margin -50164.77%

Chimerix, Inc., a developing-stage biopharmaceutical company, focuses on accelerating the advancement of various drugs that impact the lives of patients living with cancer and other serious diseases. The company is headquartered in Durham, North Carolina.

Subscribe Now For Access - Only $1.99 Per Month